文献速递炎症性肠病

ATP柠檬酸裂解酶(ACLY)依赖的黏膜T细胞免疫代谢驱动实验性结肠炎

ATP citrate lyase (ACLY)-dependent immunometabolism in mucosal T cells drives experimental colitis in vivo.
PubMed 文献 · Gut · 2024-03-07

该研究探讨黏膜T细胞中ATP柠檬酸裂解酶(ACLY)在炎症性肠病(IBD)中的免疫代谢作用。在IBD患者黏膜T细胞和两种实验性结肠炎模型中分析ACLY表达及其对致结肠炎T细胞功能的影响。结果显示ACLY在实验性结肠炎和IBD患者炎症肠道浸润的CD4+ T细胞中显著下调,ACLY缺陷的CD4+ T细胞诱导肠道炎症的能力受损,丁酸可抑制T细胞ACLY表达,而丁酸前药三丁酸甘油酯可改善慢性结肠炎。

要点

  • ACLY在实验性结肠炎和IBD患者炎症肠道CD4+ T细胞中显著下调。
  • ACLY缺陷CD4+ T细胞诱导肠道炎症的能力较野生型T细胞受损。
  • 丁酸抑制T细胞ACLY表达,三丁酸甘油酯改善慢性结肠炎。

核心结论

  • ACLY调控黏膜T细胞免疫代谢和实验性结肠炎,靶向调节T细胞ACLY表达是促进肠道炎症消退的新策略。

研究设计与样本

  • 在IBD患者黏膜T细胞和两种实验性结肠炎模型中分析ACLY表达及其对致结肠炎T细胞功能的免疫代谢影响。

主要发现

  • ACLY在稳态结肠组织中明显表达,但在实验性葡聚糖硫酸钠诱导结肠炎及IBD患者炎症肠道浸润的CD4+ T细胞(程度较轻的CD8+ T细胞)中显著下调。
  • ACLY缺陷CD4+ T细胞在转移性结肠炎模型中诱导肠道炎症的能力较野生型T细胞受损。
  • ACLY缺陷减弱IBD相关细胞因子的产生和糖酵解ATP生成,但富集参与磷脂和磷脂酰胆碱生物合成的代谢物。
  • 短链脂肪酸丁酸是T细胞ACLY表达的有效抑制因子,而IL-36α和消退素E1诱导ACLY水平。
  • 体内给予丁酸前药三丁酸甘油酯下调ACLY高表达CD4+ T细胞的黏膜浸润并改善慢性结肠炎。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Mucosal T cells play a major role in inflammatory bowel disease (IBD). However, their immunometabolism during intestinal inflammation is poorly understood. Due to its impact on cellular metabolism and proinflammatory immune cell function, we here focus on the enzyme ATP citrate lyase (ACLY) in mucosal T cell immunometabolism and its relevance for IBD. DESIGN: ACLY expression and its immunometabolic impact on colitogenic T cell function were analysed in mucosal T cells from patients with IBD and in two experimental colitis models. RESULTS: ACLY was markedly expressed in colon tissue under steady-state conditions but was significantly downregulated in lamina propria mononuclear cells in experimental dextran sodium sulfate-induced colitis and in CD4+ and to a lesser extent in CD8+ T cells infiltrating the inflamed gut in patients with IBD. ACLY-deficient CD4+ T cells showed an impaired capacity to induce intestinal inflammation in a transfer colitis model as compared with wild-type T cells. Assessment of T cell immunometabolism revealed that ACLY deficiency dampened the production of IBD-relevant cytokines and impaired glycolytic ATP production but enriched metabolites involved in the biosynthesis of phospholipids and phosphatidylcholine. Interestingly, the short-chain fatty acid butyrate was identified as a potent suppressor of ACLY expression in T cells, while IL-36α and resolvin E1 induced ACLY levels. In a translational approach, in vivo administration of the butyrate prodrug tributyrin downregulated mucosal infiltration of ACLYhigh CD4+ T cells and ameliorated chronic colitis. CONCLUSION: ACLY controls mucosal T cell immunometabolism and experimental colitis. Therapeutic modulation of ACLY expression in T cells emerges as a novel strategy to promote the resolution of intestinal inflammation.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Schulz-Kuhnt A, Rühle K, Javidmehr A, et al. ATP citrate lyase (ACLY)-dependent immunometabolism in mucosal T cells drives experimental colitis in vivo. Gut. 2024. PMID: 38176897. doi:10.1136/gutjnl-2023-330543

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。